title: Primary lymphedema: clinical features and management in 138 pediatric patients.
abstract: BACKGROUND
  Lymphedema results from maldevelopment of the lymphatic system (primary) or injury to lymphatic vasculature (secondary). Primary lymphedema is far less common than the secondary condition. The purpose of this study was to determine the clinical features of primary lymphedema in the pediatric age group.
  
  
  METHODS
  The authors' Vascular Anomalies Center database was reviewed for patients evaluated between 1999 and 2010 with onset of lymphedema before 21 years of age. Cause, sex, age of onset, location, and familial/syndromic association were determined. Morbidity, progression, and treatment were analyzed.
  
  
  RESULTS
  Lymphedema was confirmed in 142 children: 138 cases (97.2 percent) were primary and four (2.8 percent) were secondary. Analysis of the primary cohort showed that 58.7 percent of the patients were female. Age of onset was infancy, 49.2 percent; childhood, 9.5 percent; or adolescence, 41.3 percent. Boys most commonly presented in infancy (68.0 percent), whereas girls usually developed swelling in adolescence (55.3 percent). Lymphedema involved an extremity (81.9 percent), genitalia (4.3 percent), or both (13.8 percent). The lower limb was most commonly affected (91.7 percent), and 52.9 percent had bilateral lower extremity disease. Eleven percent of patients had familial or syndromic lymphedema. Cellulitis occurred in 18.8 percent of children; 13.0 percent required hospitalization. The majority of patients (57.9 percent) had progression of their disease. Treatment was compression garments alone (75.4 percent) or in combination with pneumatic compression (19.6 percent); 13.0 percent had operative intervention.
  
  
  CONCLUSIONS
  Pediatric primary lymphedema usually involves the lower extremities. Boys typically are affected at birth, and girls most often present during adolescence. Most patients do not have major morbidity, are successfully managed by compression, and do not require surgical treatment.
authors: Boston, Mass. From the Departments of Plastic and Oral Surgery, Surgery, and Radiology, Vascular Anomalies Center, Children's Hospital Boston, Harvard Medical School.
authors: Carolyn C
authors: CC
authors: Schook
authors: John B
authors: JB
authors: Mulliken
authors: Steven J
authors: SJ
authors: Fishman
authors: Frederick D
authors: FD
authors: Grant
authors: David
authors: D
authors: Zurakowski
authors: Arin K
authors: AK
authors: Greene
references: Brorson H. Adipose tissue in lymphedema: The ignorance of adipose tissue in lymphedema. Lymphology 2004;37:175–177.
references: Lymphatic filariasis: Fourth report of the WHO Expert Committee on Filariasis. World Health Organ Tech Rep Ser. 1984;702:3–112.
references: Rockson SG, Rivera KK. Estimating the population burden of lymphedema. Ann NY Acad Sci. 2008;1131:147–154.
references: Smeltzer DM, Stickler GB, Schirger A. Primary lymphedema in children and adolescents: A follow-up study and review. Pediatrics 1985;76:206–218.
references: Kinmonth JB, Taylor GW, Tracy GD, Marsh JD. Primary lymphoedema; clinical and lymphangiographic studies of a series of 107 patients in which the lower limbs were affected. Br J Surg. 1957;45:1–9.
references: Gough MH. Primary lymphoedema: Clinical and lymphangiographic studies. Br J Surg. 1966;53:917–925.
references: Saijo M, Munro IR, Mancer K. Lymphedema: A clinical review and follow-up study. Plast Reconstr Surg. 1975;56:513–521.
references: O'Brien BM, Das SK, Franklin JD, Morrison WA. Effect of lymphangiography on lymphedema. Plast Reconstr Surg. 1981;68:922–926.
references: Lewis JM, Wald ER. Lymphedema praecox. J Pediatr. 1984;104:641–648.
references: Browse NL. The diagnosis and management of primary lymphedema. J Vasc Surg. 1986;3:181–184.
references: Hilliard RI, McKendry JB, Phillips MJ. Congenital abnormalities of the lymphatic system: A new clinical classification. Pediatrics 1990;86:988–994.
references: Herman-Giddens ME, Slora EJ, Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: A study from the Pediatric Research in Office Settings network. Pediatrics 1997;99:505–512.
references: Irwin CE, Shafer M, Moscicki A. The adolescent patient. In: Rudolph AM, Rudolph CD, Hostetter MK, Lister G, Siegel NJ, eds. Rudolph's Pediatrics. 21st ed. New York: McGraw-Hill; 2003:223.
references: Lee PA. Normal ages of pubertal events among American males and females. J Adolesc Health Care 1980;1:26–29.
references: Liu AS, Mulliken JB, Zurakowski D, Fishman SJ, Greene AK. Extracranial arteriovenous malformations: Natural progression and recurrence after treatment. Plast Reconstr Surg. 2010;125:1185–1194.
references: Nonne M. Vier Fälle von Elephantiasis congenita hereditaria. Virchows Arch Pathol Anat Physiol Klin Med. 1891:189–196.
references: Milroy W. An undescribed variety of hereditary oedema. NY Med J. 1892;56:505–508.
references: Milroy W. Chronic hereditary edema: Milroy's disease. JAMA 1928;91:1172–1175.
references: Brouillard P, Vikkula M. Genetic causes of vascular malformations. Hum Mol Genet. 2007;16:R140–R149.
references: Connell FC, Ostergaard P, Carver C, et al. Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas. Hum Genet. 2009;124:625–631.
references: Meige H. Dystrophie oedematose hereditaire. Presse Med. 1898;6:341–343.
references: Goodman R. Familial lymphedema of the Meige's type. Am J Med. 1962;32:651–656.
references: Fang J, Dagenais SL, Erickson RP, et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet. 2000;67:1382–1388.
references: Erickson RP, Dagenais SL, Caulder MS, et al. Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations. J Med Genet. 2001;38:761–766.
references: Falls HF, Kertesz ED. A new syndrome combining pterygium colli with developmental anomalies of the eyelids and lymphatics of the lower extremities. Trans Am Ophthalmol Soc. 1964;62:248–275.
references: Hennekam RC, Geerdink RA, Hamel BC, et al. Autosomal recessive intestinal lymphangiectasia and lymphedema, with facial anomalies and mental retardation. Am J Med Genet. 1989;34:593–600.
references: Alders M, Hogan BM, Gjini E, et al. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat Genet. 2009;41:1272–1274.
references: Turner H. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology 1938;23:566–574.
references: Noonan JA. Hypertelorism with Turner phenotype: A new syndrome with associated congenital heart disease. Am J Dis Child. 1968;116:373–380.
references: Tartaglia M, Mehler EL, Goldberg R, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29:465–468.
references: Wiedemann HR, Glatzl J. Follow-up of Ullrich's original patient with “Ullrich-Turner” syndrome. Am J Med Genet. 1991;41:134–136.
references: Loscalzo ML. Turner syndrome. Pediatr Rev. 2008;29:219–227.
references: Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69:412–422.
references: Greene AK, Karnes J, Padua HM, Schmidt BA, Kasser JR, Labow BI. Diffuse lipofibromatosis of the lower extremity masquerading as a vascular anomaly. Ann Plast Surg. 2009;62:703–706.
references: Alomari AI. Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: A descriptive study of 18 cases of CLOVES syndrome. Clin Dysmorphol. 2009;18:1–7.
references: Allen E. Lymphedema of the extremities. Arch Intern Med. 1934;56:606–624.
references: Wolfe JH, Kinmonth JB. The prognosis of primary lymphedema of the lower limbs. Arch Surg. 1981;116:1157–1160.
references: Schirger A. Postoperative lymphedema: Etiologic and diagnostic factors. Med Clin North Am. 1962;46:1045–1050.
references: Brunner U. Natural history of primary lymphedema of the legs. Pathol Microbiol (Basel) 1975;43:230–234.
references: Fonkalsrud EW. A syndrome of congenital lymphedema of the upper extremity and associated systemic lymphatic malformations. Surg Gynecol Obstet. 1977;145:228–234.
references: Levine C. Primary disorders of the lymphatic vessels: A unified concept. J Pediatr Surg. 1989;24:233–240.
references: Wright NB, Carty HM. The swollen leg and primary lymphoedema. Arch Dis Child. 1994;71:44–49.
references: Browse NL, Stewart G. Lymphoedema: Pathophysiology and classification. J Cardiovasc Surg. 1985;26:91–106.
references: Fonkalsrud E, Coulson W. Management of congenital lymphedema in infants and children. Ann Surg. 1973;177:280–285.
references: Schirger A, Harrison EG Jr, Janes JM. Idiopathic lymphedema: Review of 131 cases. JAMA 1962;182:14–22.
references: Brice G, Child AH, Evans A, et al. Milroy disease and the VEGFR-3 mutation phenotype. J Med Genet. 2005;42:98–102.
references: Ghalamkarpour A, Holnthoner W, Saharinen P, et al. Recessive primary congenital lymphoedema caused by a VEGFR3 mutation. J Med Genet. 2009;46:399–404.
references: Karkkainen MJ, Ferrell RE, Lawrence EC, et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet. 2000;25:153–159.
references: Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K, Vikkula M. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet. 2000;67:295–301.
references: Ghalamkarpour A, Morlot S, Raas-Rothschild A, et al. Hereditary lymphedema type I associated with VEGFR3 mutation: The first de novo case and atypical presentations. Clin Genet. 2006;70:330–335.
references: Carver C, Brice G, Mansour S, et al. Three children with Milroy disease and de novo mutations in VEGFR3. Clin Genet. 2007;71:187–189.
references: Connell F, Brice G, Jeffery S, Keeley V, Mortimer P, Mansour S. A new classification system for primary lymphatic dysplasias based on phenotype. Clin Genet. 2010;77:438–452.
references: Rezaie T, Ghoroghchian R, Bell R, et al. Primary non-syndromic lymphoedema (Meige disease) is not caused by mutations in FOXC2. Eur J Hum Genet. 2008;16:300–304.
references: Moffatt CJ, Franks PJ, Doherty DC, et al. Lymphoedema: An underestimated health problem. QJM. 2003;96:731–738.
references: Stewart F, Treves N. Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica. Cancer 1948;1:64–81.
references: Stemmer R. A clinical symptom for the early and differential diagnosis of lymphedema (in German). Vasa 1976;5:261–262.
references: Stemmer R. Stemmer's sign: Possibilities and limits of clinical diagnosis of lymphedema (in German). Wien Med Wochenschr. 1999;149:85–86.
references: Szuba A, Shin WS, Strauss HW, Rockson S. The third circulation: Radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003;44:43–57.
references: Schmitz KH, Ahmed RL, Troxel A, et al. Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med. 2009;361:664–673.
references: Moseley AL, Carati CJ, Piller NB. A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment. Ann Oncol. 2007;18:639–646.
references: Andersen L, Højris I, Erlandsen M, Andersen J. Treatment of breast-cancer-related lymphedema with or without manual lymphatic drainage: A randomized study. Acta Oncol. 2000;39:399–405.
references: Williams AF, Vadgama A, Franks PJ, Mortimer PS. A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-related lymphoedema. Eur J Cancer Care (Engl.) 2002;11:254–261.
references: Bergan J, Sparks S, Angle N. A comparison of compression pumps in the treatment of lymphedema. Vasc Surg. 1998;32:455–462.
references: Richmand DM, O'Donnell TF Jr, Zelikovski A. Sequential pneumatic compression for lymphedema: A controlled trial. Arch Surg. 1985;120:1116–1119.
references: Tiwari A, Cheng KS, Button M, Myint F, Hamilton G. Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch Surg. 2003;138:152–161.
references: Szuba A, Rockson SG. Lymphedema: Classification, diagnosis and therapy. Vasc Med. 1998;3:145–156.
references: Casley-Smith JR, Casley-Smith JR. Frequency of coumarin hepatotoxicity. Med J Aust. 1995;162:391–395.
references: Loprinzi CL, Sloan J, Kugler J. Coumarin-induced hepatotoxicity. J Clin Oncol. 1997;15:3167–3168.
references: O'Brien BM, Mellow CG, Khazanchi RK, Dvir E, Kumar V, Pederson WC. Long-term results after microlymphaticovenous anastomoses for the treatment of obstructive lymphedema. Plast Reconstr Surg. 1990;85:562–572.
references: Goldsmith HS. Long term evaluation of omental transposition for chronic lymphedema. Ann Surg. 1974;180:847–849.
references: Greene AK, Slavin SA, Borud L. Treatment of lower extremity lymphedema with suction-assisted lipectomy. Plast Reconstr Surg. 2006;118:118e–121e.
references: Brorson H, Ohlin K, Olsson G, Svensson B, Svensson H. Controlled compression and liposuction treatment for lower extremity lymphedema. Lymphology 2008;41:52–63.
references: Miller TA. Charles procedure for lymphedema: A warning. Am J Surg. 1980;139:290–292.